Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AI Briefing

• – Ultragenyx Pharmaceutical Inc. awards 10,839 restricted stock units to two new non-executive officers under Nasdaq Listing Rule 5635(c)(4).
• – The grants were approved by the company's board of directors and granted under the Ultragenyx Employment Inducement Plan.
• – The awards were made as an inducement to new employees entering into employment with the company.